Natdac 60 mg

Tags: +

Product description

We are leading exporter of Natdac to Russia. Natdac (Daclatasvir Dihydrochloride) is a treatment for chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection. It is always prescribed with sofosbuvir, and depending on the genotype and underlying medical conditions, with or without ribavirin. Daclatasvir (NatDac) is the first-in-class NS5A inhibitor used in combination with Sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 3 infection. Compared to other treatment options, this combination not only increases the cure rate, but is also regarded as a valuable treatment option in some of the difficult-to-treat HCV patient subsets. NATDAC 60 mg - Brand Name: Natdac Content: Daclatasvir Manufactured by: Natco Pharma Ltd. Strengths: 60 mg Form: Tablets Packing: Pack of 28 Tablets

Subscribe for latest offers and updates.

we hate spam too